PETALING JAYA: CCM Duopharma Biotech Bhd
(CCMD) has obtained shareholders approval to take over Chemical Co of Malaysia Bhd’s (CCM) pharmaceutical arm in a deal that is valued at RM245.1mil.
The purchase of the six pharmaceutical units from its parent company includes CCM Pharmaceuticals Sdn Bhd, CCM Pharma Sdn Bhd, Innovax Sdn Bhd, Upha Pharmaceutical Manufacturing (M) Sdn Bhd, CCM International (Philippines) Inc and CCM Pharmaceuticals (S) Pte Ltd.
Already a subscriber? Log in
5.5 PAYDAY OFFER: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
